Everyday Health on MSN
How to manage eosinophilic esophagitis during allergy season
ON THIS PAGEWhy They're LinkedWhat to Do for AllergiesIf you have eosinophilic esophagitis (EoE), you may also have allergies, either in the form of allergic rhinitis or food allergies. Thats not a ...
Everyday Health on MSN
Your eosinophilic esophagitis and asthma action plan
ON THIS PAGEWhy EoE and Asthma Are LinkedHow to Manage EoE and AsthmaAt first glance, eosinophilic esophagitis (EoE) and asthma may seem like two very different conditions. The former causes ...
Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and ...
Revolo completes patient enrollment in phase 2 trial of ‘1104 in eosinophilic esophagitis: New Orleans Wednesday, September 14, 2022, 14:30 Hrs [IST] Revolo Biotherapeutics (Rev ...
Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitisApproval in adults and ...
Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitisApproval in adults and children aged 6 years and older supported by phase 3 study ...
Sanofi today announced the appointment of Manuela Buxo as Head of Specialty Care, effective March 1, 2026. Manuela will ...
Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST My name is Julianne, and I will be your conference facilitator today for the Amgen Q4 2025 Earnings Conference Call. [Operator ...
FARE's indicator report tracks the growing public health challenge of food allergy in the United States—a top-tier public health issue—highlighting key data that can guide future research efforts.
Frequent dry eyes may signal more than simple irritation and could be an early warning sign of an autoimmune disease. This ...
Executives at Amgen (NASDAQ:AMGN) outlined several upcoming clinical milestones and recent data updates across its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results